Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Alcoholic Povidone-Iodine |
| Active Ingredient: | Povidone-iodine 100mg/mL equivalent to iodine 1%w/v |
| Dosage Form: | Topical solution |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturer: | Pfizer (Perth) Pty Limited, Perth, Australia |
| Product: | Danica 35 ED |
| Active Ingredients: | Cyproterone acetate 2mg Ethinylestradiol 0.035mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Mylan New Zealand Limited |
| Manufacturer: | Mylan Laboratories Limited, Ahmedabad, India |
| Product: | Ganciclovir SXP |
| Active Ingredient: | Ganciclovir sodium 543mg equivalent to ganciclovir 500mg |
| Dosage Form: | Powder for injection |
| New Zealand Sponsor: | Southern Cross Pharma NZ Limited |
| Manufacturer: | Laboratorio Reig Jofre SA, Barcelona, Spain |
| Product: | Half Strength Povidone-Iodine |
| Active Ingredient: | Povidone-iodine 50mg/mL equivalent to iodine 0.5%w/v |
| Dosage Form: | Topical solution |
| New Zealand Sponsor: | Pfizer New Zealand Limited |
| Manufacturer: | Pfizer (Perth) Pty Limited, Perth, Australia |
Dated this 26th day of February 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).